Harvard Bioscience, Inc.HBIONASDAQ
Loading
Cash Generation ExpandingExpanding
Percentile Rank71
3Y CAGR+80.1%
5Y CAGR-6.3%
Year-over-Year Change
Cash generated from core business operations
3Y CAGR
+80.1%/yr
vs -16.3%/yr prior
5Y CAGR
-6.3%/yr
Recent acceleration
Acceleration
+96.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $6.73M | +367.3% |
| 2024 | $1.44M | -89.7% |
| 2023 | $14.03M | +1117.7% |
| 2022 | $1.15M | -8.7% |
| 2021 | $1.26M | -86.5% |
| 2020 | $9.33M | +16.0% |
| 2019 | $8.05M | +243.3% |
| 2018 | $2.34M | +121.8% |
| 2017 | $1.06M | -80.4% |
| 2016 | $5.38M | - |